Insights

Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, <i>PTAB Litigation Blog</i>

Federal Circuit Holds Objective Indicia Must Be Linked to Novel Features, PTAB Litigation Blog

Visit the Jones Day PTAB Litigation.

In Novartis AG v. Torrent Pharms. Ltd. (2016-1352), the Federal Circuit affirmed the PTAB’s decision in consolidated IPR proceedings (IPR2014-00784, IPR2015-00518) invalidating all claims of U.S. Patent 8,324,283. In doing so, the court affirmed the PTAB’s finding that Novartis’ evidence on the objective indicia of nonobviousness lacked sufficient nexus to the claimed invention to warrant a different outcome.

Read the full article at ptablitigationblog.com.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.